Deep Brain Stimulation (DBS)
Deep brain stimulation is a neurosurgical procedure in which electrodes are implanted into specific brain regions and connected to a pulse generator. In neurodegeneration, DBS is best viewed as an advanced symptomatic circuit therapy, most established in Parkinson’s disease and also used in selected movement disorders such as dystonia and tremor.
Biological Rationale
In Parkinson’s disease, abnormal activity develops in motor circuits as dopamine signaling declines. These circuits include deep brain structures that help regulate movement initiation, smoothness, and suppression of unwanted motor activity. DBS does not replace dopamine or remove pathology. Instead, it modulates dysfunctional circuit activity, which can improve tremor, rigidity, motor fluctuations, and in some cases allow reduction in levodopa exposure. The benefit comes from changing how abnormal signals move through the network, rather than repairing the underlying neurodegenerative process.
Evidence Strength
Strong
The evidence is strong for carefully selected Parkinson’s patients with disabling motor complications. DBS is not first-line therapy nor is it for every Parkinson’s patient, but in the right population it has durable clinical value and is one of the clearest examples of procedure-based symptom control in neurodegeneration. Patients most likely to benefit are typically those who still respond to levodopa but have complications such as medication wearing-off, dyskinesias, or medication-refractory tremor. Its effects can be long-lasting, but outcomes depend heavily on patient selection, surgical targeting, programming, and follow-up care.
Limitations
DBS is not disease-modifying. It requires surgery, careful patient selection, programming, and follow-up, and it does not reliably treat all Parkinson’s symptoms, especially dementia, major postural instability, or broad non-motor decline. It can also have mood, cognitive, speech, or other stimulation-related side effects.
Sources
- Weaver, F. M., Follett, K., Stern, M., et al. (2009). Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial.
- Lyons, M. K. (2011). Deep brain stimulation: current and future clinical applications
- Deuschl, G., Schade-Brittinger, C., Krack, P., et al. (2006). A randomized trial of deep-brain stimulation for Parkinson’s disease.
- National Institute of Neurological Disorders and Stroke. (2024). Deep Brain Stimulation (DBS) for the Treatment of Parkinson’s Disease and Other Movement Disorders.
- Weaver, F. M., Follett, K. A., Stern, M., et al. (2012). Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.